Updated
Updated · Community Impact · Jun 26
PCOS Renamed PMOS to Highlight 3 Key Metabolic Risks
Updated
Updated · Community Impact · Jun 26

PCOS Renamed PMOS to Highlight 3 Key Metabolic Risks

2 articles · Updated · Community Impact · Jun 26

Summary

  • Polycystic ovarian syndrome is now being called polyendocrine metabolic ovarian syndrome, or PMOS, in a push to improve patient care by broadening how the condition is understood.
  • Dr. Neha Lalani said the new name centers the disorder’s metabolic side, including insulin resistance, cardiovascular complications and other symptoms that can shape long-term health.
  • The old PCOS label often framed the condition mainly as a gynecological problem tied to irregular periods and fertility, which she said led patients and clinicians to underweight underlying metabolic issues.

Insights

Will renaming PCOS finally force a focus on the metabolic risks threatening millions of women?
Beyond a new name, how will the shift to PMOS overhaul treatment for 170 million women worldwide?